Details for New Drug Application (NDA): 009182
✉ Email this page to a colleague
NDA 009182 describes GANTRISIN, which is a drug marketed by Roche and is included in five NDAs. Additional details are available on the GANTRISIN profile page.
The generic ingredient in GANTRISIN is sulfisoxazole. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole profile page.
The generic ingredient in GANTRISIN is sulfisoxazole. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole profile page.
Summary for 009182
| Tradename: | GANTRISIN |
| Applicant: | Roche |
| Ingredient: | sulfisoxazole acetyl |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | EQ 500MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 500MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 009
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | EMULSION;ORAL | Strength | EQ 1GM BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
